カテゴリ： 世界, 医療/バイオ, QYResearch

レチノイドの世界市場2023年：アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン

■ 英語タイトル：Global Retinoids Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA3123）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA3123
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：73
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[レチノイドの世界市場2023年：アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はレチノイドのグローバル市場について調査・分析し、世界のレチノイド市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン）、用途別セグメント分析（皮膚病、白血病）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Chongqing Huabang、Cheplapharm Arzneimittel、OLON S.P.A、Siegfried Evionnazなどが含まれています。レチノイドのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、レチノイド市場規模を算出する際に考慮しました。

・レチノイド市場の概要
- 製品の定義
- レチノイドの種類別セグメント
- 世界のレチノイド市場規模：タイプ別分析（アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン）
- レチノイドの用途別セグメント
- 世界のレチノイド市場規模：用途別分析（皮膚病、白血病）
- 世界のレチノイド市場規模予測（2018年-2029年）
- レチノイドの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- レチノイド市場の競争状況およびトレンド

・レチノイドの地域別市場規模
- 北米のレチノイド市場規模（2018年-2029年）
- 米国のレチノイド市場規模（2018年-2029年）
- ヨーロッパのレチノイド市場規模（2018年-2029年）
- アジア太平洋のレチノイド市場規模（2018年-2029年）
- 中国のレチノイド市場規模（2018年-2029年）
- 日本のレチノイド市場規模（2018年-2029年）
- 韓国のレチノイド市場規模（2018年-2029年）
- インドのレチノイド市場規模（2018年-2029年）
- オーストラリアのレチノイド市場規模（2018年-2029年）
- 中南米のレチノイド市場規模（2018年-2029年）
- 中東・アフリカのレチノイド市場規模（2018年-2029年）

・種類別セグメント：アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン
- 世界のレチノイドのタイプ別販売量（2018年-2023年）
- 世界のレチノイドのタイプ別売上（2018年-2023年）
- 世界のレチノイドのタイプ別価格

・用途別セグメント：皮膚病、白血病
- 世界のレチノイドの用途別販売量（2018年-2023年）
- 世界のレチノイドの用途別売上（2018年-2023年）
- 世界のレチノイドの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Chongqing Huabang、Cheplapharm Arzneimittel、OLON S.P.A、Siegfried Evionnaz

・産業チェーンと販売チャネルの分析
- レチノイド産業チェーン分析
- レチノイドの主要原材料
- レチノイドの販売チャネル
- レチノイドのディストリビューター
- レチノイドの主要顧客

・レチノイド市場ダイナミクス
- レチノイドの業界動向
- レチノイド市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

The retinoids are a class of chemical compounds that are vitamers of vitamin A or are chemically related to it.
Highlights
The global Retinoids market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Retinoids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Retinoids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Retinoids include Chongqing Huabang, Cheplapharm Arzneimittel, OLON S.P.A and Siegfried Evionnaz, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Retinoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinoids.
The Retinoids market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Retinoids market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retinoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chongqing Huabang
Cheplapharm Arzneimittel
OLON S.P.A
Siegfried Evionnaz
Segment by Type
Acitretin
Adapalene
Alitretinoin
Bexarotene
Isotretionoin
Tazarotene
Tretinoin
Segment by Application
Skin Disease
Leukemia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Retinoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Retinoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Retinoids Market Overview
1.1 Product Overview and Scope of Retinoids
1.2 Retinoids Segment by Type
1.2.1 Global Retinoids Market Value Comparison by Type (2023-2029)
1.2.2 Acitretin
1.2.3 Adapalene
1.2.4 Alitretinoin
1.2.5 Bexarotene
1.2.6 Isotretionoin
1.2.7 Tazarotene
1.2.8 Tretinoin
1.3 Retinoids Segment by Application
1.3.1 Global Retinoids Market Value by Application: (2023-2029)
1.3.2 Skin Disease
1.3.3 Leukemia
1.4 Global Retinoids Market Size Estimates and Forecasts
1.4.1 Global Retinoids Revenue 2018-2029
1.4.2 Global Retinoids Sales 2018-2029
1.4.3 Global Retinoids Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Retinoids Market Competition by Manufacturers
2.1 Global Retinoids Sales Market Share by Manufacturers (2018-2023)
2.2 Global Retinoids Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Retinoids Average Price by Manufacturers (2018-2023)
2.4 Global Retinoids Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Retinoids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Retinoids, Product Type & Application
2.7 Retinoids Market Competitive Situation and Trends
2.7.1 Retinoids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Retinoids Players Market Share by Revenue
2.7.3 Global Retinoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Retinoids Retrospective Market Scenario by Region
3.1 Global Retinoids Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Retinoids Global Retinoids Sales by Region: 2018-2029
3.2.1 Global Retinoids Sales by Region: 2018-2023
3.2.2 Global Retinoids Sales by Region: 2024-2029
3.3 Global Retinoids Global Retinoids Revenue by Region: 2018-2029
3.3.1 Global Retinoids Revenue by Region: 2018-2023
3.3.2 Global Retinoids Revenue by Region: 2024-2029
3.4 North America Retinoids Market Facts & Figures by Country
3.4.1 North America Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Retinoids Sales by Country (2018-2029)
3.4.3 North America Retinoids Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Retinoids Market Facts & Figures by Country
3.5.1 Europe Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Retinoids Sales by Country (2018-2029)
3.5.3 Europe Retinoids Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Retinoids Market Facts & Figures by Country
3.6.1 Asia Pacific Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Retinoids Sales by Country (2018-2029)
3.6.3 Asia Pacific Retinoids Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Retinoids Market Facts & Figures by Country
3.7.1 Latin America Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Retinoids Sales by Country (2018-2029)
3.7.3 Latin America Retinoids Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Retinoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Retinoids Sales by Country (2018-2029)
3.8.3 Middle East and Africa Retinoids Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Retinoids Sales by Type (2018-2029)
4.1.1 Global Retinoids Sales by Type (2018-2023)
4.1.2 Global Retinoids Sales by Type (2024-2029)
4.1.3 Global Retinoids Sales Market Share by Type (2018-2029)
4.2 Global Retinoids Revenue by Type (2018-2029)
4.2.1 Global Retinoids Revenue by Type (2018-2023)
4.2.2 Global Retinoids Revenue by Type (2024-2029)
4.2.3 Global Retinoids Revenue Market Share by Type (2018-2029)
4.3 Global Retinoids Price by Type (2018-2029)
5 Segment by Application
5.1 Global Retinoids Sales by Application (2018-2029)
5.1.1 Global Retinoids Sales by Application (2018-2023)
5.1.2 Global Retinoids Sales by Application (2024-2029)
5.1.3 Global Retinoids Sales Market Share by Application (2018-2029)
5.2 Global Retinoids Revenue by Application (2018-2029)
5.2.1 Global Retinoids Revenue by Application (2018-2023)
5.2.2 Global Retinoids Revenue by Application (2024-2029)
5.2.3 Global Retinoids Revenue Market Share by Application (2018-2029)
5.3 Global Retinoids Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chongqing Huabang
6.1.1 Chongqing Huabang Corporation Information
6.1.2 Chongqing Huabang Description and Business Overview
6.1.3 Chongqing Huabang Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chongqing Huabang Retinoids Product Portfolio
6.1.5 Chongqing Huabang Recent Developments/Updates
6.2 Cheplapharm Arzneimittel
6.2.1 Cheplapharm Arzneimittel Corporation Information
6.2.2 Cheplapharm Arzneimittel Description and Business Overview
6.2.3 Cheplapharm Arzneimittel Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cheplapharm Arzneimittel Retinoids Product Portfolio
6.2.5 Cheplapharm Arzneimittel Recent Developments/Updates
6.3 OLON S.P.A
6.3.1 OLON S.P.A Corporation Information
6.3.2 OLON S.P.A Description and Business Overview
6.3.3 OLON S.P.A Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.3.4 OLON S.P.A Retinoids Product Portfolio
6.3.5 OLON S.P.A Recent Developments/Updates
6.4 Siegfried Evionnaz
6.4.1 Siegfried Evionnaz Corporation Information
6.4.2 Siegfried Evionnaz Description and Business Overview
6.4.3 Siegfried Evionnaz Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siegfried Evionnaz Retinoids Product Portfolio
6.4.5 Siegfried Evionnaz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Retinoids Industry Chain Analysis
7.2 Retinoids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Retinoids Production Mode & Process
7.4 Retinoids Sales and Marketing
7.4.1 Retinoids Sales Channels
7.4.2 Retinoids Distributors
7.5 Retinoids Customers
8 Retinoids Market Dynamics
8.1 Retinoids Industry Trends
8.2 Retinoids Market Drivers
8.3 Retinoids Market Challenges
8.4 Retinoids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Retinoids Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Retinoids Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Retinoids Market Competitive Situation by Manufacturers in 2022
Table 4. Global Retinoids Sales (Tons) of Key Manufacturers (2018-2023)
Table 5. Global Retinoids Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Retinoids Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Retinoids Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Retinoids Average Price (US$/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Retinoids, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Retinoids, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Retinoids, Product Type & Application
Table 12. Global Key Manufacturers of Retinoids, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Retinoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinoids as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Retinoids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Retinoids Sales by Region (2018-2023) & (Tons)
Table 18. Global Retinoids Sales Market Share by Region (2018-2023)
Table 19. Global Retinoids Sales by Region (2024-2029) & (Tons)
Table 20. Global Retinoids Sales Market Share by Region (2024-2029)
Table 21. Global Retinoids Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Retinoids Revenue Market Share by Region (2018-2023)
Table 23. Global Retinoids Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Retinoids Revenue Market Share by Region (2024-2029)
Table 25. North America Retinoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Retinoids Sales by Country (2018-2023) & (Tons)
Table 27. North America Retinoids Sales by Country (2024-2029) & (Tons)
Table 28. North America Retinoids Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Retinoids Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Retinoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Retinoids Sales by Country (2018-2023) & (Tons)
Table 32. Europe Retinoids Sales by Country (2024-2029) & (Tons)
Table 33. Europe Retinoids Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Retinoids Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Retinoids Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Retinoids Sales by Region (2018-2023) & (Tons)
Table 37. Asia Pacific Retinoids Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Retinoids Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Retinoids Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Retinoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Retinoids Sales by Country (2018-2023) & (Tons)
Table 42. Latin America Retinoids Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Retinoids Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Retinoids Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Retinoids Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Retinoids Sales by Country (2018-2023) & (Tons)
Table 47. Middle East & Africa Retinoids Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Retinoids Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Retinoids Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Retinoids Sales (Tons) by Type (2018-2023)
Table 51. Global Retinoids Sales (Tons) by Type (2024-2029)
Table 52. Global Retinoids Sales Market Share by Type (2018-2023)
Table 53. Global Retinoids Sales Market Share by Type (2024-2029)
Table 54. Global Retinoids Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Retinoids Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Retinoids Revenue Market Share by Type (2018-2023)
Table 57. Global Retinoids Revenue Market Share by Type (2024-2029)
Table 58. Global Retinoids Price (US$/Ton) by Type (2018-2023)
Table 59. Global Retinoids Price (US$/Ton) by Type (2024-2029)
Table 60. Global Retinoids Sales (Tons) by Application (2018-2023)
Table 61. Global Retinoids Sales (Tons) by Application (2024-2029)
Table 62. Global Retinoids Sales Market Share by Application (2018-2023)
Table 63. Global Retinoids Sales Market Share by Application (2024-2029)
Table 64. Global Retinoids Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Retinoids Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Retinoids Revenue Market Share by Application (2018-2023)
Table 67. Global Retinoids Revenue Market Share by Application (2024-2029)
Table 68. Global Retinoids Price (US$/Ton) by Application (2018-2023)
Table 69. Global Retinoids Price (US$/Ton) by Application (2024-2029)
Table 70. Chongqing Huabang Corporation Information
Table 71. Chongqing Huabang Description and Business Overview
Table 72. Chongqing Huabang Retinoids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 73. Chongqing Huabang Retinoids Product
Table 74. Chongqing Huabang Recent Developments/Updates
Table 75. Cheplapharm Arzneimittel Corporation Information
Table 76. Cheplapharm Arzneimittel Description and Business Overview
Table 77. Cheplapharm Arzneimittel Retinoids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 78. Cheplapharm Arzneimittel Retinoids Product
Table 79. Cheplapharm Arzneimittel Recent Developments/Updates
Table 80. OLON S.P.A Corporation Information
Table 81. OLON S.P.A Description and Business Overview
Table 82. OLON S.P.A Retinoids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. OLON S.P.A Retinoids Product
Table 84. OLON S.P.A Recent Developments/Updates
Table 85. Siegfried Evionnaz Corporation Information
Table 86. Siegfried Evionnaz Description and Business Overview
Table 87. Siegfried Evionnaz Retinoids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Siegfried Evionnaz Retinoids Product
Table 89. Siegfried Evionnaz Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Retinoids Distributors List
Table 93. Retinoids Customers List
Table 94. Retinoids Market Trends
Table 95. Retinoids Market Drivers
Table 96. Retinoids Market Challenges
Table 97. Retinoids Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Retinoids
Figure 2. Global Retinoids Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Retinoids Market Share by Type in 2022 & 2029
Figure 4. Acitretin Product Picture
Figure 5. Adapalene Product Picture
Figure 6. Alitretinoin Product Picture
Figure 7. Bexarotene Product Picture
Figure 8. Isotretionoin Product Picture
Figure 9. Tazarotene Product Picture
Figure 10. Tretinoin Product Picture
Figure 11. Global Retinoids Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Retinoids Market Share by Application in 2022 & 2029
Figure 13. Skin Disease
Figure 14. Leukemia
Figure 15. Global Retinoids Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Retinoids Market Size (2018-2029) & (US$ Million)
Figure 17. Global Retinoids Sales (2018-2029) & (Tons)
Figure 18. Global Retinoids Average Price (US$/Ton) & (2018-2029)
Figure 19. Retinoids Report Years Considered
Figure 20. Retinoids Sales Share by Manufacturers in 2022
Figure 21. Global Retinoids Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Retinoids Players: Market Share by Revenue in 2022
Figure 23. Retinoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Retinoids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Retinoids Sales Market Share by Country (2018-2029)
Figure 26. North America Retinoids Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Retinoids Sales Market Share by Country (2018-2029)
Figure 30. Europe Retinoids Revenue Market Share by Country (2018-2029)
Figure 31. Germany Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Retinoids Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Retinoids Revenue Market Share by Region (2018-2029)
Figure 38. China Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Taiwan Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Philippines Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Retinoids Sales Market Share by Country (2018-2029)
Figure 49. Latin America Retinoids Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Retinoids Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Retinoids Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. U.A.E Retinoids Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Retinoids by Type (2018-2029)
Figure 59. Global Revenue Market Share of Retinoids by Type (2018-2029)
Figure 60. Global Retinoids Price (US$/Ton) by Type (2018-2029)
Figure 61. Global Sales Market Share of Retinoids by Application (2018-2029)
Figure 62. Global Revenue Market Share of Retinoids by Application (2018-2029)
Figure 63. Global Retinoids Price (US$/Ton) by Application (2018-2029)
Figure 64. Retinoids Value Chain
Figure 65. Retinoids Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • EMR＆ESDナイフの世界市場インサイト・予測（～2028年）
  • 内服薬シリンジの世界市場2023年：1ml、5ml、10ml、その他
  • ヨウ素-125の世界市場2023年：ヨウ素99%以上、その他
  • ペット用抗生剤の世界市場2023年：粉末、液体
  • ノイズキャンセリングスリープエイドヘッドフォンの世界市場2023年：ヘッドマウント、インイヤー、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA3123 )"レチノイドの世界市場2023年：アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン" (英文：Global Retinoids Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。